# Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil

> **NCT00518336** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 433 (actual)

## Conditions studied

- Infections, Papillomavirus

## Interventions

- **PROCEDURE:** Blood sampling
- **PROCEDURE:** Collection of cervical specimen
- **BIOLOGICAL:** Cervarix

## Key facts

- **NCT ID:** NCT00518336
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-07
- **Final completion:** 2010-09
- **Target enrollment:** 433 (ACTUAL)
- **Last updated:** 2016-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518336, "Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00518336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*